A Gene Transfer Study to Evaluate the Safety, Tolerability and Efficacy of SRP-6004 in Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2B/R2 (LGMD2B/R2, Dysferlin [DYSF] Related)
Clinical trial NCT05906251 · TERMINATED
Trial details
- NCT number
- NCT05906251
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-22
- Primary completion
- 2025-06-13
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.